Ligand-controlled regulation of endogenous gene expression
US7070934B2 · kind B2 · utility
172Cited by
44References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2003 |
| Grant date | Jul 4, 2006 |
| Priority date | — |
| Expiry date | Mar 30, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/57
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions comprising an engineered zinc finger protein and a nuclear hormone receptor transcriptional control domain, polynucleotides encoding one or more components of the compositions, methods of making the compositions and methods of using these compositions, for example to modulate gene expression and/or to generate transgenic plants or animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.